Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
Phase 1 Terminated
12 enrolled
Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities
Phase 1 Terminated
9 enrolled
SADDRIN-1
Phase 1 Terminated
12 enrolled
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
Phase 1 Terminated
31 enrolled
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Phase 1 Terminated
10 enrolled
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
94 enrolled 28 charts
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
Phase 1 Terminated
20 enrolled
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Phase 1 Terminated
272 enrolled
FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors
Phase 1 Terminated
55 enrolled
A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
Phase 1 Terminated
9 enrolled 10 charts
CAR
Phase 1 Terminated
9 enrolled
CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas
Phase 1 Terminated
9 enrolled
Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
Phase 1 Terminated
74 enrolled
Camsirubicin + Pegfilgrastim to Determine MTD in ASTS
Phase 1 Terminated
14 enrolled
Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
Phase 1 Terminated
27 enrolled
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 16 charts
NYESO SCT
Phase 1 Terminated
5 enrolled
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
Phase 1 Terminated
2 enrolled
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Phase 1 Terminated
56 enrolled
Safety Study of MGD009 in B7-H3-expressing Tumors
Phase 1 Terminated
67 enrolled
FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas
Phase 1 Terminated
5 enrolled
A Safety Study of SGN-CD47M in Patients With Solid Tumors
Phase 1 Terminated
16 enrolled
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Phase 1 Terminated
79 enrolled
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Phase 1 Terminated
10 enrolled
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
Phase 1 Terminated
19 enrolled
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
Phase 1 Terminated
21 enrolled
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
Phase 1 Terminated
39 enrolled
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
Phase 1 Terminated
6 enrolled 12 charts
Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal
Phase 1 Terminated
41 enrolled
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
Phase 1 Terminated
5 enrolled 15 charts
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
Phase 1 Terminated
Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma
Phase 1 Terminated
18 enrolled
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Phase 1 Terminated
31 enrolled 12 charts
ODSH + ICE Chemotherapy in Pediatric Solid Tumors
Phase 1 Terminated
4 enrolled
MT2004-30: Tomotherapy for Solid Tumors
Phase 1 Terminated
23 enrolled
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Phase 1 Terminated
13 enrolled
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
Phase 1 Terminated
7 enrolled
Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas
Phase 1 Terminated
17 enrolled 6 charts
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
Phase 1 Terminated
14 enrolled
Cryosurgery in Treating Patients With Soft Tissue Sarcoma
Phase 1 Terminated
19 enrolled
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
Phase 1 Terminated
1 enrolled
Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors
Phase 1 Terminated
12 enrolled
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Phase 1 Terminated
24 enrolled 10 charts
EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
Phase 1 Terminated
30 enrolled
Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma
Phase 1 Terminated
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Phase 1 Terminated
38 enrolled
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Phase 1 Terminated
3 enrolled